Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.
2.
'The Pitt' Actor's Cancer Diagnosis; New HHS Research Plans; Madonna Reveals Injury
3.
In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.
4.
Single-dose radiation before surgery can eradicate breast cancer
5.
Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.
1.
Personalized Neoantigen Vaccines and the Promise of a Less Toxic Future in Pediatric Oncology
2.
Preventing Developmental Iron Depletion in Childhood
3.
Early Recognition of Immune-Related Adverse Events During Cancer Therapy
4.
How Cancer Cells Evade Immune Destruction and the Fight Back
5.
Molecular Residual Disease Profiles in Cancer: Clinical Implications and Emerging Paradigms
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
4.
Understanding the Role of Screening in Cancer Prevention
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation